Objectives: To provide an update on the impact of new information about the molecular biology of chronic leukemia and new treatment modalities available to patients.
Data Sources: Published articles, books, and research studies.
Conclusion: There has been significant progress in the diagnosis and management of chronic myeloid and chronic lymphocytic leukemia.